FDA sets new COVID booster guidelines requiring trials for approvals for healthy adults

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability this fall to older adults and those with a higher risk of developing severe illness, FDA leaders said on Tuesday.